Bristol-Myers Squibb Co (BMY) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Technical Indicators
|
|
|
Bearish (15)
Neutral (8)
Bullish (4)
Performance
BMY ROI
% from 52W High
52W Low: $39.66
05 Jul 2024
52W High: $59.82
11 Nov 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
